Director Shareholding

Oxford Biomedica PLC
29 May 2001

                       Oxford BioMedica ('the Company')



                    Director's Share Options and Dealings


The Company has today granted options over 3,185,253 1p ordinary shares
('Ordinary Shares') at an exercise price of 53.5 pence per share, to Dr. Doug
Jolly, who was today appointed CEO of the Company's US operation, BioMedica
Inc.


The above options are exercisable as to 25% from the 29 May 2002, with the
balance becoming exercisable over the period up to 29 May 2005. The options
cease to be exercisable on 29 May 2011.


In connection with his appointment, Dr. Jolly has today subscribed for 50,000
Ordinary Shares at a price of 53.5 pence per Ordinary Share, representing
0.02% of the Company's current issued ordinary share capital.




FURTHER INFORMATION


Andrew Wood, Oxford BioMedica     01865 783000






29 May 2001